Global Depression Drugs Market 2015-2019

  • TEC250594
  • 107 Pages
  • June 2015
  • Pharmaceuticals
About depression drugs

According to the WHO, depression is a common mental disorder that contributes significantly to the global burden of disease. It affects people across communities
worldwide. It is characterized by sadness, loss of interest or pleasure, feelings of guilt or low self-worth, disturbed sleep or appetite, feelings of tiredness, and
poor concentration. Depression can be roughly categorized into six different types. An individual with severe depression can have suicidal thoughts and behaviors.
According to a 2012 estimate by the WHO, about 3,000 suicides take place each day, resulting in more than a million deaths each year. Depression can be recurrent and
can be severely debilitating. Patients with mild depression can be treated with medications, but in cases of moderate or severe depression, the patient needs both
medication and professional psychotherapy in the form of counseling. According to a 2008 report by the WHO, depression affects men and women equally, but women are
more likely to be affected by depression

than men. According to the CDC, depression can lead to many adverse behaviors in an individual such as alcoholism, smoking, and sleep disturbance. According to the CDC
factsheet, in the US, one in every 10 individuals is affected by depression. According to the NIMH in the US, major depressive disorder is one of the most debilitating
disorders in the US and affects about 14.80 million adults aged 18 years and above.

Technavio's analysts forecast the global depression drugs market to grow at a CAGR of 5.25% over the period 2014-2019.

Covered in this report

This report covers the present scenario and the growth prospects of the global depression drugs market for the period 2015-2019. To calculate the market size, the
report considers revenue generated from the sales of various drugs used for the treatment of depression. The global depression drugs market is segmented based on the
mechanism of action of the drugs used to treat depression, as mentioned below:

Tricyclic antidepressants
Serotonin-norepinephrine reuptake inhibitors
Selective serotonin reuptake inhibitors
Monoamine oxidase inhibitors

Technavio's report, Global Depression Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key regions

Key vendors
Bristol-Myers Squibb
Eli Lilly

Other prominent vendors
Abbott Laboratories
Addex Therapeutics
Aurobindo Pharma
Avanir Pharmaceuticals
Chugai Pharmaceutical
Dart NeuroScience
Dr. Reddy's Laboratories
Edgemont Pharmaceuticals
F. Hoffmann-La Roche
Fabre Kramer
Gedeon Richter
H. Lundbeck
Intra-Cellular Therapies
Janssen Pharmaceuticals
Luye Pharma
MSI Methylation Sciences
Opko Health
Otsuka Pharmaceutical
Pierre Fabre
SK Biopharmaceuticals
Somerset Pharmaceuticals
Sun Pharmaceutical
Sunovion Pharmaceuticals
Takeda Pharmaceutical
Teva Pharmaceutical
Torrent Pharmaceuticals
Valeant Pharmaceuticals

Market driver
Rise in patient population
For a full, detailed list, view our report

Market challenge
Threat of expiry of patents
For a full, detailed list, view our report

Market trend
Growing public awareness
For a full, detailed list, view our report

Key questions answered in this report
What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?
Please Select Format

Enquiry About Report

Need More Information

Contact us
+ 1-800-910-6452
+91 20 66346066
--- or ---



Global General Medicine Education Publishing Market (Type, Geography) Size, Share, Global Trends, Company Profiles, Demand, Insights, Analysis, Opportunities, Segmentation, Forecast (2013-2020)

General medicine is a branch of medicine that deals with diagnosis and treatment of diseases associated with internal organs. It is also called as Internal Medicine. General medicine education market has shown substantial growth due to the adoption of internal medicine as a career option by medical students.

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370


Cancer Vaccine Market Global Scenario, Market Size, Outlook, Trend and Forecast, 2015- 2024

Cancer vaccines are biological response modifiers. These vaccines work by stimulating or restoring the immune system�s ability to fight against infections and diseases. It is used either as stand-alone therapies ...

July 2017  |   Price:$ 4995    | Pre Book Price:$ 4995


World Active Pharmaceutical Ingredient (API) Market - Opportunities and Forecasts, 2014 - 2020

Increase in Abbreviated New Drug Applications (ANDA) over the past years has fostered the demand for API market. Furthermore, Indian companies making increased entries related to Drug Master File (DMF) ...

July 2017  |   Price:$ 5370    | Pre Book Price:$ 5370


Anterior Uveitis Asia-Pacific Market Research Report, 2014 - 2020

Anterior uveitis is an eye inflammation that involves middle layer of the eye specifically, iris (colored part of the eye) and ciliary body (adjacent tissue). Untreated anterior uveitis results in ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850


Nanomedicine Asia-Pacific Market Research Report, 2014 - 2020

Nanomedicine is the applied branch of nanotechnology. Application of nanomedicines ranges from nonmaterial to nanoelectronic and in the near future, it could possibly expand to molecular nanotechnology. Biological, pharmaceutical and ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850


Autoimmune Disorders Treatment Asia-Pacific Market Research Report, 2014 - 2020

Graves disease, Multiple sclerosis, Myasthenia gravis, Rheumatoid arthritis, Pernicious anemia and Systemic lupus erythematosus are the most prevalent types of autoimmune disorders. The prevalence of autoimmune diseases is high in ...

July 2017  |   Price:$ 2850    | Pre Book Price:$ 2850


2017 © Copyright Big Market Research

View Pricing >>